IRIS - Res&Arch Institutional Research Information System - Research & Archive

MOMI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.326
EU - Europa 1.085
AS - Asia 413
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 2.827
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.322
IE - Irlanda 270
UA - Ucraina 248
IT - Italia 197
HK - Hong Kong 134
SE - Svezia 116
SG - Singapore 90
VN - Vietnam 83
CN - Cina 74
RU - Federazione Russa 61
FI - Finlandia 59
DE - Germania 49
GB - Regno Unito 35
FR - Francia 13
TR - Turchia 11
KR - Corea 8
BE - Belgio 7
CH - Svizzera 6
UZ - Uzbekistan 5
AT - Austria 4
LB - Libano 4
CA - Canada 3
CZ - Repubblica Ceca 3
PL - Polonia 3
RO - Romania 3
BG - Bulgaria 2
ES - Italia 2
GR - Grecia 2
PH - Filippine 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
CR - Costa Rica 1
EU - Europa 1
IN - India 1
MK - Macedonia 1
NL - Olanda 1
NO - Norvegia 1
TW - Taiwan 1
Totale 2.827
Salva come PNG Salva come JPEG
Città #
Chandler 326
Dublin 265
San Mateo 146
Jacksonville 139
Hong Kong 134
Dong Ket 83
Perugia 78
Altamura 77
Medford 63
Princeton 63
Lawrence 57
Ann Arbor 51
Wilmington 51
Singapore 50
Beijing 32
Andover 29
Des Moines 27
Saint Petersburg 21
Dearborn 17
San Paolo di Civitate 12
Woodbridge 12
Izmir 11
New York 10
Los Angeles 9
Norwalk 9
Seoul 8
Ashburn 7
Boardman 7
Brussels 7
Helsinki 7
Auburn Hills 4
Falls Church 4
Moscow 4
Shanghai 4
Amelia 3
Menlo Park 3
Olomouc 3
Ottawa 3
Rome 3
Southwark 3
Granarolo dell'Emilia e Viadagola 2
Gubbio 2
Houston 2
Ludwigshafen 2
Madrid 2
Narni 2
Newton Stewart 2
Parma 2
Redwood City 2
San Diego 2
Siegen 2
Sofia 2
Timisoara 2
Ugong Norte 2
Alameda 1
Bucharest 1
Clearwater 1
Corciano 1
Den Haag 1
Falkenstein 1
Frankfurt Am Main 1
Fuzhou 1
Hebei 1
Kiev 1
Lausanne 1
Logan 1
London 1
New Orleans 1
Philadelphia 1
Redmond 1
San José 1
Taipei 1
Vancouver 1
Vijayawada 1
Wuhan 1
Zurich 1
Totale 1.892
Salva come PNG Salva come JPEG
Nome #
Interaction with damaged vessel wall in vivo in humans induces platelets to express CD40L resulting in endothelial activation. No effect of aspirin intake. 84
RhoA signaling through platelet P2Y1 receptor controls leukocyte recruitment in allergic mice. 82
Platelets are essential for leukocyte recruitment in allergic inflammation. 78
Nitric oxide and its antithrombotic action on the cardiovascular system 77
Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo. 76
Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome. 69
Nitric oxide-donating aspirin (NCX 4016): an overview of its pharmacological properties and clinical perspectives. 67
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. 66
Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation 65
A novel mechanism regulating human platelet activation by MMP-2-mediated PAR1 biased signaling 64
Anti-platelet therapy: phosphodiesterase inhibitors. 63
Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. 61
Matrix metalloproteinases and peripheral arterial disease. 59
Contribution of matrix metalloproteinase 2 to joint destruction in group B Streptococcus-induced murine arthritis. 59
A novel nitric oxide-releasing statin derivative exerts and antiplatelet/antithrombotic activity and inhibits tissue factor expression. 58
Defective platelet beta-N-Acetyl hexosaminidase content and release in chronic myeloproliferative disorders 57
Allergen induces the migration of platelets to lung tissue in allergic asthma. 57
Mechanisms of thrombocytopenia in platelet-type von Willebrand disease 56
Endothelium, venous thromboembolism and ischaemic cardiovascular events. 54
Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders. 53
Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis. 52
Platelets release matrix metalloproteinase-2 in the coronary circulation of patients with acute coronary syndromes: possible role in sustained platelet activation. 50
Established and new antiplatelet therapies 49
Platelets contribute to the accumulation of matrix metalloproteinase type 2 in synovial fluid in osteoarthritis 49
Matrix metalloproteinase-2 of human carotid atherosclerotic plaques promotes platelet activation. Correlation with ischaemic events. 48
Anti-platelet treatments in cancer: Basic and clinical research 48
Platelet Priming. 47
Visualization of nitric oxide production by individual platelets during adhesion in flowing blood. 47
Chemotaxis and phagocytosis 46
AB0952 Intra-articular low molecular weight hyaluronate reduces platelet influx and matrix metalloproteinase-2 levels in synovial fluid of patients with knee osteoarthritis 46
Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function. 45
Matrix metalloproteinase-2 enhances platelet deposition on collagen under flow conditions 45
Platelet-targeted pharmacologic treatments as anti-cancer therapy 44
Involvement of platelets in experimental mouse trypanosomiasis: evidence of mouse platelet cytotoxicity against Trypanosoma equiperdum. 43
NCX4016: a novel antithrombotic agent. 43
Prevalence of hemostatic alterations in patients with recurrent spontaneous subconjunctival hemorrhage 43
A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression. 42
Prevention of pulmonary thromboembolism by NCX 4016, a nitric oxide-releasing aspirin. 41
Low molecular weight heparins prevent thrombin-induced thromboembolism in mice despite low antithrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition. 41
Interactions of gallic acid, resveratrol, quercetin and aspirin at the platelet cyclooxygenase-1 level. Functional and modelling studies. 41
A dichotomy in platelet activation: Evidence of different functional platelet responses to inflammatory versus haemostatic stimuli 40
Nitroaspirin plus clopidogrel versus aspirin plus clopidogrel against platelet thromboembolism and intimal thickening in mice 39
Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome. 39
Highly Active Antiretroviral Therapy-related Mechanisms of Endothelial and Platelets Function Alterations 38
HYPERGLYCEMIA-INDUCED PLATELET ACTIVATION IN TYPE 2 DIABETES MELLITUS IS RESISTANT TO ASPIRIN BUT NOT TO A NITRIC OXIDE-DONATING AGENT. 38
Nitric oxide-enhancing or -releasing agents as antithrombotic drugs. 37
Trombocitopenia da eparina nel paziente dializzato 37
Impaired thrombin-induced platelet activation and thrombus formation in mice lacking the Ca(2+)-dependent tyrosine kinase Pyk2. 36
Endogenous nitric oxide acts as a natural antithrombotic agent in vivo by inhibiting platelet aggregation in the pulmonary vasculature. 36
Platelets in respiratory disorders and inflammatory conditions. 35
NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties. 34
Matrix Metalloproteinases and Platelet Function 32
The effect of defibrotide on thromboembolism in the pulmonary vasculature of mice and rabbits and in the cerebral vasculature of rabbits 31
Role of Platelets in the Pathogenesis of Osteoarthritis and Biological Effects of Hyaluronic Acid: in Vivo and in Vitro Study 31
Potentiation and priming of platelet activation: a potential target for antiplatelet therapy. 30
Platelets and chemotaxis. 29
PCSK9 in Haemostasis and Thrombosis: Possible Pleiotropic Effects of PCSK9 Inhibitors in Cardiovascular Prevention 29
Platelets are necessary for airway wall remodeling in a murine model of chronic allergic inflammation. 28
Reperfusion of cerebral artery thrombosis by the GPIb-VWF blockade with the Nanobody ALX-0081 reduces brain infarct size in guinea pigs. 28
Stroke prevention: from available antiplatelet drugs to novel molecular targets. 22
Matrix metalloproteinase-2 on activated platelets triggers endothelial PAR-1 initiating atherosclerosis 20
Stimulation of platelet nitric oxide production by nebivolol prevents thrombosis. 19
Platelet dysfunction in platelet-type von Willebrand disease due to the constitutive triggering of the Lyn-PECAM1 inhibitory pathway 18
Totale 2.941
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.944
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.944
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020246 5 3 34 3 37 13 40 11 44 27 6 23
2020/2021522 4 34 14 40 156 24 44 2 51 15 46 92
2021/2022507 12 110 12 26 9 10 7 147 7 19 69 79
2022/20231.002 70 232 10 71 78 104 0 48 338 3 30 18
2023/2024381 19 42 18 5 2 4 99 9 46 12 77 48
2024/20256 6 0 0 0 0 0 0 0 0 0 0 0
Totale 2.941